{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieuqj6d3iijbsrouxraxrky7qavsym26535fjiw37lei2fxxhfxyy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mmpiq7zlfzv2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicd5jw7ylhcdcrfxalgs7brg7gadqachh7epezzt6bqte7dw3xy6q"
    },
    "mimeType": "image/jpeg",
    "size": 149928
  },
  "path": "/news/2026-05-maternal-rsv-vaccine-lowers-infant.html",
  "publishedAt": "2026-05-25T18:00:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Respiratory syncytial virus (RSV) is a common respiratory virus that can cause severe breathing complications in babies, especially those younger than 6 months old. While many adults recover quickly from RSV with mild symptoms similar to a cold, infants often face a much greater risk of hospitalization due to their developing immune systems and smaller airways. One hundred to 300 children aged less than 5 years die of RSV each year.",
  "title": "New maternal RSV vaccine lowers infant hospitalization rates, but accessibility may be limited, study finds"
}